High 8-OHdG Compounds Concentration and Lymphovascular Invasion Are Risk Factors For Increases Invasive Breast Cancer Behavior

2019 ◽  
Vol 50 (1) ◽  
Author(s):  
Wayan Tianing
2009 ◽  
Vol 12 (4) ◽  
pp. 302 ◽  
Author(s):  
On Vox Yi ◽  
Jong Won Lee ◽  
Hee Jung Kim ◽  
Woo Sung Lim ◽  
Eun Hwa Park ◽  
...  

2019 ◽  
Vol 45 (2) ◽  
pp. e26
Author(s):  
A. Saad Abdalla ◽  
A. Asaad ◽  
P. Idaewor ◽  
M. Barron ◽  
M. Elamass ◽  
...  

2008 ◽  
Vol 168 (4) ◽  
pp. 404-411 ◽  
Author(s):  
B. L. Sprague ◽  
A. Trentham-Dietz ◽  
K. M. Egan ◽  
L. Titus-Ernstoff ◽  
J. M. Hampton ◽  
...  

2017 ◽  
Vol 46 (4) ◽  
pp. 1037-1044 ◽  
Author(s):  
Hyejin Cheon ◽  
Hye Jung Kim ◽  
So Mi Lee ◽  
Seung Hyun Cho ◽  
Kyung Min Shin ◽  
...  

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 1530-1530
Author(s):  
J. Mershon ◽  
M. Geiger ◽  
E. Barrett-Connor ◽  
P. Collins ◽  
M. Kornitzer ◽  
...  

1530 Background: RUTH enrolled 10,101 postmenopausal women at increased risk for major coronary events. Women were not enrolled based on their risk for breast cancer. The incidence of invasive breast cancer in the placebo group was low for this older population of women (mean age 67.5 years). The aim of this analysis was to determine whether CHD risk factors and selected cardiac medications were protective against invasive breast cancer in this population at increased risk for coronary events. Methods: Covariates assessed were baseline factors that are known CHD risk factors and selected medications ( Table ). Univariate analyses were performed for all covariates using placebo data. Results: The effect of baseline CHD risk factors and selected cardiac medications on the incidence of invasive breast cancer in women receiving placebo in RUTH (N=5057) Conclusions: In these postmenopausal women at increased risk for major coronary events, baseline CHD risk factors and selected cardiac medications assessed individually did not protect against invasive breast cancer. The low incidence of invasive breast cancer in the RUTH population does not appear to be due to the presence of CHD risk factors or use of cardiac medications. [Table: see text] [Table: see text]


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Maya Alsheh Ali ◽  
Kamila Czene ◽  
Per Hall ◽  
Keith Humphreys

Abstract Using for-presentation and for-processing digital mammograms, the presence of microcalcifications has been shown to be associated with short-term risk of breast cancer. In a previous article we developed an algorithm for microcalcification cluster detection from for-presentation digital mammograms. Here, we focus on digitised mammograms and use a three-step algorithm. In total, 253 incident invasive breast cancer cases (with a negative mammogram between three months and two years before diagnosis, from which we measured microcalcifications) and 728 controls (also with prior mammograms) were included in a short-term risk study. After adjusting for potential confounding variables, we found evidence of an association between the number of microcalcification clusters and short-term (within 3–24 months) invasive breast cancer risk (per cluster OR = 1.30, 95% CI = (1.11, 1.53)). Using the 728 postmenopausal healthy controls, we also examined association of microcalcification clusters with reproductive factors and other established breast cancer risk factors. Age was positively associated with the presence of microcalcification clusters (p = 4 × 10−04). Of ten other risk factors that we studied, life time breastfeeding duration had the strongest evidence of association with the presence of microcalcifications (positively associated, unadjusted p = 0.001). Developing algorithms, such as ours, which can be applied on both digitised and digital mammograms (in particular for presentation images), is important because large epidemiological studies, for deriving markers of (clinical) risk prediction of breast cancer and prognosis, can be based on images from these different formats.


Sign in / Sign up

Export Citation Format

Share Document